Family based association study of DRD1, DRD2, DRD3, DRD4, DAT, COMT gene polymorphism in schizophrenia;Asocjacyjne badania rodzinne polimorfizmów genów DRD1, DRD2, DRD3, DRD4, DAT, COMT w schizofrenii

Psychiatria Polska

Volumn 44, Issue 3, 2010, Pages 405-413

  Kapelski, Paweł ^b   Hauser, Joanna ^a,b   Skibińska, Maria ^a   Szczepankiewicz, Aleksandra ^a   Dmitrzak Wȩglarz, Monika ^a   Gorzkowska, Karolina ^a   Pawlak, Joanna ^b   Czerski, Piotr M ^a  

^a Zakład Genetyki W Psychiatrii Katedry Psychiatrii UM W Poznaniu ^*  (Poland)

^b Poznan University of Medical Sciences   (Poland)

Author keywords

Dopamine; Polymorphism; Schizophrenia

Indexed keywords

CATECHOL METHYLTRANSFERASE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE TRANSPORTER; DRD4 PROTEIN, HUMAN;

ADULT; ALLELE; ARTICLE; CHILD; CONTROLLED STUDY; DNA EXTRACTION; FAMILY; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; LEUKOCYTE; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCHIZOPHRENIA; STATISTICAL ANALYSIS; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; FEMALE; GENETIC PREDISPOSITION; GENETICS; MALE;

ADULT; CHILD; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; RECEPTORS, DOPAMINE D4; SCHIZOPHRENIA;

EID: 77956848331     PISSN: 00332674     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Carlsson A, Lindquist M. Effect of chlorpromazine and haloperidol on formation of 3-methoxytyramine and norepinephrine in mouse brain. Acta Pharmacol. Toxicol. 1963; 20: 140.
2. Breier A, Su TP, Saunders R, Carson RE, Kolachana BS, de Bartolomeis A, Weinberger DR, Weisenfeld N, Malhotra AK, Eckelman WC, Pickar D. Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. Proc. Nat. Acad. Sc. USA 1997; 94 (6): 2569-2574.
3. Wolfarth S, Ossowska K. Farmakologia leków przeciwpsychotycznych. W: Bijak M, Lasoń W, red. Neuropsychofarmakologia dziś i jutro. Kraków: Instytut Farmakologii PAN; 2000, s. 9-26.
4. Crow TJ. Positive and negative schizophrenic symptoms and the role of dopamine. Brit. J. Psychiatry 1980; 137: 383.
5. Andreasen NC, Olsen S. Negative versus positive schizophrenia: Definition and validation. Arch. Gen. Psychiatry 1982; 39: 789.
6. Seeman P. Dopamine receptors and the dopamine hypothesis of schizophrenia. Synapse 1987; 1 (2): 133-152.
7. Pużyński S, Rybakowski J. Neurobiologia zaburzeń psychicznych. W: Bilikiewicz A, Pużyński S, Rybakowski J, Wiórka J, red. Psychiatria. Tom I. Wrocław: Wydawnictwo Medyczne Urban & Partner; 2002, s. 151-178.
8. Abi-Dargham A, Rodenhiser J, Printz D, Zea-Ponce Y, Gil R, Kegeles LS, Weiss R, Cooper TB, Mann JJ, Van Heertum RL, Gorman JM, Laruelle M. From the cover: increased baseline occupancy of D2 receptors by dopamine in schizophrenia. Proc. Nat. Acad Sc. USA 2000; 97 (14): 8104-8109.
9. Callicott JH, Bertolino A, Mattay VS, Langheim FJ, Duyn J, Coppola R, Goldberg TE, Weinberger DR. Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited. Cereb. Cortex 2000; 10 (11): 1078-1092.
10. Kapur S, Mizrahi R, Li M. From dopamine to salience to psychosis - linking biology, pharmacology and phenomenology of psychosis. Schizophr. Res. 2005; 79 (1): 59-68.
11. Di Forti M, Lappin JM, Murray RM. Risk factors for schizophrenia - all roads lead to dopamine. Eur. Neuropsychopharmacol. 2007; 17, supl. 2: 101-107.
12. Diagnostic and statistical manual of mental disorders. Fourth edition. Washington, D.C.: American Psychiatric Association; 1994.
13. International classification of diseases - tenth revision (ICD-10). The ICD-10 classification of mental and behavioural disorders: Clinical descriptions and diagnostic guidelines: Geneva: WHO; 1992.
14. First MB, Gibbon M, Spitzer RL, Williams JW. User's guide for the Structured Clinical Interview for DSM-IV Axis I Disorders - research version (SCID-I, version 2.0, February 1996 final version).
15. Miller SA, Dykes D, Plesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic. Acids. Res. 1988; 16: 1215.
16. Kang AM, Palmatier MA, Kidd KK. Global variation of a 40-bp VNTR in the 3′-untranslated region of the dopamine transporter gene (SLC6A3). Biol. Psychiatry 1999; 46 (2): 151-160.
17. McGuffin P i in. Schizophrenia. W: McGuffin P, Owen MJ, O'Donovan MV, Thapar A, Gottesman II, red. Seminars in psychiatric genetics.Londyn: Royal College of Psychiatrists; 1994, s. 87-109.
18. Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am. J. Hum. Genet. 1993; 52 (3): 506-516.
19. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinform. 2005; 21 (2): 263-265.
20. Sanders AR, Duan J, Levinson DF, Shi J, He D, Hou C, Burrell GJ, Rice JP, Nertney DA, Olincy A, Rozic P, Vinogradov S, Buccola NG, Mowry BJ, Freedman R, Amin F, Black DW, Silverman JM, Byerley WF, Crowe RR, Cloninger CR, Martinez M, Gejman PV. No significant association of 14 candidate genes with schizophrenia in a large European ancestry sample: implications for psychiatric genetics. Am. J. Psychiatry 2008;165 (4): 497-506. E-pub. 2008, Jan. 15. Erratum in: Am. J. Psychiatry 2008;165 (10): 1359.
21. Shi J, Gershon ES, Liu C. Genetic associations with schizophrenia: meta-analyses of 12 candidate genes. Schizophr. Res. 2008;104 (1-3): 96-107. E-pub. 2008, Aug. 20.
22. Gamma F, Faraone SV, Glatt SJ, Yeh YC, Tsuang MT. Meta-analysis shows schizophrenia is not associated with the 40-base-pair repeat polymorphism of the dopamine transporter gene. Schizophr. Res. 2005 1; 73 (1): 55-58.
23. Allen NC, Bagade S, McQueen MB, Ioannidis JP, Kavvoura FK, Khoury MJ, Tanzi RE, Bertram L. Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat. Genet. 2008; 40 (7): 827-834.
24. Williams J, Spurlock G, Holmans P, Mant R, Murphy K, Jones L, Cardno A, Asherson P, Blackwood D, Muir W, Meszaros K, Aschauer H, Mallet J, Laurent C, Pekkarinen P, Seppala J, Stefanis CN, Papadimitriou GN, Macciardi F, Verga M, Pato C, Azevedo H, Crocq MA, Gurling H, Owen MJ i in. A meta-analysis and transmission disequilibrium study of association between the dopamine D3 receptor gene and schizophrenia. Mol. Psychiatry 1998; 3 (2): 141-149.
25. Owen MJ, O'Donovan MC, Gottesman II. Schizophrenia. W: McGuffin P, Owen MJ, Gottesman II, red. Psychiatric genetics and genomics. Oxford University Press; 2002, s. 247-266.